Get started
Author

Lei Ji

ORCID: 0000-0002-6608-6009
Observed ORCID: 0000-0002-6608-6009
OpenAlex ID: A5149076640
Genetic and biochemical screens identify MGAT1 as a druggable glycosyltransferase target in STK11-mutant lung cancer
2026 · Kiera M. Vassallo, Ying-nan P. Chen, et al. · Journal of Biological Chemistry
Supplementary Figure S2 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Table S5 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Table S6 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Figure S6 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Table S8 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Table S7 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Table S4 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Figure S8 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Figure S5 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Table S2 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Table S1 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Figure S1 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Figure S7 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Data from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Figure S3 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Table S3 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Figure S4 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al. · Cancer Research
Works count: 19
Citation count:
H-index:
I10-index:
Year
Topic
Type